हिंदी में पढ़ें

Dr Reddy's Laboratories

Dr Reddy's Labs gets Rs 27 lakh penalty from Mexican drug regulator

Dr Reddy's Labs gets Rs 27 lakh penalty from Mexican drug regulator

Thu, Nov 14, 2024

The fine was imposed due to an error in the date of the invoice and also in the name of the reference standard versus import license.

Dr Reddy's fined Rs 28 lakh by Mexican drug regulator

Dr Reddy's fined Rs 28 lakh by Mexican drug regulator

Thu, Sep 26, 2024

The drug regulatory body of Mexico has imposed a penalty of MXN 6,51,420 (Rs 28 Lakh) on the company for deviation from prescribed guidelines for filing intimation of import of a reference standard for one of the active pharmaceutical ingredient

Dr Reddy's Laboratories share price: Company gets establishment inspection report from USFDA for Visakhapatnam units

Dr Reddy's Laboratories share price: Company gets establishment inspection report from USFDA for Visakhapatnam units

Mon, Aug 12, 2024

Earlier, the USFDA had issued a Form 483 with two observations to the two units following inspection which was conducted from May 8 to May 17, 2024.

TRENDING NOW

USFDA to re-audit Dr Reddy's three plants in first quarter of 2017

USFDA to re-audit Dr Reddy's three plants in first quarter of 2017

Thu, Jan 12, 2017

US Food and Drug Administration (USFDA) will re-audit three manufacturing facilities of Dr Reddy's Laboratories in the current quarter.

What would a Hillary Clinton win mean for Indian Pharma?

What would a Hillary Clinton win mean for Indian Pharma?

Mon, Nov 07, 2016

The global generics sector saw a significant de-rating in YTD (year-to-date) in the CY2016 with 1-year forward P/E (price over equity) contracting by 34%, with the past one month itself witnessing an 11%.

Pharma stocks fall sharply as US drug pricing investigation nears completion

Pharma stocks fall sharply as US drug pricing investigation nears completion

Fri, Nov 04, 2016

Media reports suggest that the US Congress investigation into price hikes, that began in October 2014, may be nearing completion, culminating into charges of price collusion against companies / individuals by the year end.

FIPB to take up 19 investment proposals this week

FIPB to take up 19 investment proposals this week

Sun, Oct 23, 2016

Inter-ministerial body FIPB will this week take up 19 foreign investment proposals, including those of Dr Reddy's Laboratories and JC Decaux Advertising.

Dr Reddy's introduces Aripiprazole, USP tablets in US market; stock down 1.04%

Dr Reddy's introduces Aripiprazole, USP tablets in US market; stock down 1.04%

Thu, Oct 13, 2016

Dr Reddy's launched Aripiprazole and USP tablets in the United States (US) market on Thursday.

Dr Reddy gets listed on Dow Jones sustainability indices 2016

Dr Reddy gets listed on Dow Jones sustainability indices 2016

Tue, Sep 13, 2016

G V Prasad, Co-chairman and CEO of Dr Reddy's Laboratories said,” This listing has earned us the trust and respect of all stakeholders we serve. I see our inclusion in the Dow Jones indices as another validation of our commitment to sustainability in all aspects of our business.”

Sun, Dr Reddy's, Glenmark strengthen their US play

Sun, Dr Reddy's, Glenmark strengthen their US play

Mon, Jul 18, 2016

Domestic pharma players are in stiff competition in US market. Sun Pharma with its taking over of SPARC's ELEPSIA XR, while Dr. Reddy launching Omeprazole and Sodium bicarbonate capsules and that of Glenmark waiting for 62 ANDA's approval, plans to strenghthen their position in the US.

Brexit impact: Indian pharma seems immune, says Phillip Capital

Brexit impact: Indian pharma seems immune, says Phillip Capital

Mon, Jun 27, 2016

"Brexit has raised business concerns around the world about trade and currency fluctuations, but Indian pharma seems immune," Surya Patra and Mehul Sheth from Phillip Capital Research said in research note on June 24.

Dr Reddy's to buy eight ANDAs in US for Rs 2,300 crore

Dr Reddy's to buy eight ANDAs in US for Rs 2,300 crore

Sat, Jun 11, 2016

The company has a strong track record in the US market with over 79 filed ANDAs pending approval, of which we believe 18 have first-to-file status.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x